Surgery and new Pharmacological strategy in some atherosclerotic chronic and acute conditions

Article Sidebar

PDF HTML
Submitted: August 1, 2017
Published: Aug 1, 2017
DOI: 10.29328/journal.ascr.1001006
Keywords:
Surgery, Atherosclerotic disease, Pharmacology, Drug delivery systems, Cardiology, Cardiac surgery, CHOF

Main Article Content

Luisetto M
European Specialist in Laboratory Medicine, Hospital Pharmacist’s Manager, Independent researcher, Italy
Nili-Ahmadabadi B
Nano Drug Delivery, Chapel Hill, NC, USA
Ghulam Rasool Mashori
Professor & Director, Peoples University of Medcial & Health Sciences for Woman, Nawabshah, Pakistan

Article Details

M, L., B, N.-A., & Mashori, G. R. (2017). Surgery and new Pharmacological strategy in some atherosclerotic chronic and acute conditions. Archives of Surgery and Clinical Research, 1(1), 042–048. https://doi.org/10.29328/journal.ascr.1001006
Review Articles

Copyright (c) 2017 Luisetto M, et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Nakahara T, Dweck MR, Narula N, Pisapia D, Narula J, et al. Coronary Artery Calcification: From Mechanism to Molecular Imaging. JACC Cardiovasc Imaging. 2017; 10: 582-593. Ref.: https://goo.gl/jDdACD

Römer TJ, Brennan JF, Puppels GJ, Zwinderman AH, van Duinen SG, et al. Intravascular ultrasound combined with Raman spectroscopy to localize and quantify cholesterol and calcium salts in atherosclerotic coronary arteries. Arterioscler Thromb Vasc Biol. 2000; 20: 478-483. Ref.: https://goo.gl/VzXgbw

Ranade VV. Drug delivery systems. 4. Implants in drug delivery. J Clin Pharmacol. 1990; 30: 871-889. Ref.: https://goo.gl/bcaszv

Zhou H, Hernandez C, Goss M, Gawlik A, Exner AA. Biomedical Imaging in Implantable Drug Delivery Systems. Curr Drug Targets. 2015; 16: 672-682. Ref.: https://goo.gl/Hxup88

Maniscalco BS, Taylor KA. Calcification in coronary artery disease can be reversed by EDTA-tetracycline long-term chemotherapy. 2004; 11: 95-101. Ref.: https://goo.gl/GRwvzW

Lamas GA, FACC MD, Ian Ergui BS, Omar M Issa. Chelation Therapy for CAD. DO Expert Analysis. 2016. Ref.: https://goo.gl/WP8UWY

Avila MD, Escolar E, Lamas GA. Chelation therapy after the Trial to Assess Chelation Therapy: results of a unique trial. Curr Opin Cardiol. 2014; 29: 481-488. Ref.: https://goo.gl/TehvBS

Luisetto M, Nili-Ahmadabadi B. The Clinical Pharmacist Competence as Pharmaceutical Drug Design Tool. Research & Reviews: Journal of Hospital and Clinical Pharmacy. 2017; 3: 1-2. Ref.: https://goo.gl/D1sptg

Ernst E. Chelation therapy for coronary heart disease: An overview of all clinical investigations. Am Heart J. 2000; 140: 139-141. Ref.: https://goo.gl/QYK9vn

Avila MD, Escolar E, Lamas GA. Chelation therapy after the Trial to Assess Chelation Therapy: results of a unique trial. Curr Opin Cardiol. 2014; 29: 481-488. Ref.: https://goo.gl/Vk9bkr

King SB, Marshall JJ, Tummala PE. Revascularization for coronary artery disease: stents versus bypass surgery. Annu Rev Med. 2010; 61: 199-213. Ref.: https://goo.gl/uhUc2d